Kymera Therapeutics (KYMR) Total Liabilities: 2019-2024
Historic Total Liabilities for Kymera Therapeutics (KYMR) over the last 6 years, with Dec 2024 value amounting to $142.4 million.
- Kymera Therapeutics' Total Liabilities rose 9.78% to $155.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $155.8 million, marking a year-over-year increase of 9.78%. This contributed to the annual value of $142.4 million for FY2024, which is 21.22% down from last year.
- According to the latest figures from FY2024, Kymera Therapeutics' Total Liabilities is $142.4 million, which was down 21.22% from $180.8 million recorded in FY2023.
- Kymera Therapeutics' Total Liabilities' 5-year high stood at $203.3 million during FY2020, with a 5-year trough of $113.0 million in FY2022.
- Over the past 3 years, Kymera Therapeutics' median Total Liabilities value was $142.4 million (recorded in 2024), while the average stood at $145.4 million.
- In the last 5 years, Kymera Therapeutics' Total Liabilities skyrocketed by 147.83% in 2020 and then decreased by 28.05% in 2021.
- Yearly analysis of 5 years shows Kymera Therapeutics' Total Liabilities stood at $203.3 million in 2020, then dropped by 28.05% to $146.3 million in 2021, then fell by 22.76% to $113.0 million in 2022, then surged by 60.01% to $180.8 million in 2023, then dropped by 21.22% to $142.4 million in 2024.